XML 55 R44.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 26, 2020
USD ($)
Sep. 28, 2019
USD ($)
Sep. 26, 2020
USD ($)
segment
Sep. 28, 2019
USD ($)
Segment Reporting [Abstract]        
Number of business units | segment     3  
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact $ 204,455 $ 249,710 $ 398,055 $ 485,656
Effect of exchange rates (311) (2,420) (3,416) (4,781)
Net revenues 209,486 252,566 405,063 491,017
Operating (loss) income 58,782 49,739 70,497 36,437
Effect of exchange rates 3,647 2,501 4,358 5,270
Amortization 8,136 5,935 16,399 11,909
Restructuring and turnaround costs (4,440) (3,757) (8,440) (5,784)
Operating Expenses, Transaction Costs (1,773) 0 (3,063) 0
PCS2 accelerated depreciation and related costs (644) (6,534) (2,186) (12,062)
European Medical Device Regulation costs and other (736) 180 (1,489) 147
Impairment of assets and related costs 68 (54) (896) (51,220)
Gain on sale of assets 31,498 8,083 31,498 8,083
United States        
Segment Reporting Information [Line Items]        
Net revenues 123,984 161,880 234,993 318,255
Japan        
Segment Reporting Information [Line Items]        
Net revenues 19,645 20,376 36,476 35,843
Europe        
Segment Reporting Information [Line Items]        
Net revenues 38,648 38,074 81,667 74,827
Asia        
Segment Reporting Information [Line Items]        
Net revenues 26,168 30,192 48,552 58,833
Other        
Segment Reporting Information [Line Items]        
Net revenues 1,041 2,044 3,375 3,259
Service        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 5,342 5,276 10,424 10,142
Plasma products and services        
Segment Reporting Information [Line Items]        
Net revenues 97,710 135,849 186,423 265,594
Blood Center products and services        
Segment Reporting Information [Line Items]        
Net revenues 59,233 65,615 119,900 125,522
Hospital products and services        
Segment Reporting Information [Line Items]        
Net revenues 52,543 51,102 98,740 99,901
Plasma        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 78,718 116,381 147,433 227,144
Blood Center        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 74,715 83,667 154,029 161,663
Hospital        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 51,022 49,662 96,593 96,849
Operating Segments        
Segment Reporting Information [Line Items]        
Operating (loss) income 96,039 118,835 188,917 229,195
Operating Segments | Plasma        
Segment Reporting Information [Line Items]        
Operating (loss) income 40,823 56,776 77,173 110,501
Operating Segments | Blood Center        
Segment Reporting Information [Line Items]        
Operating (loss) income 33,757 41,208 72,502 78,927
Operating Segments | Hospital        
Segment Reporting Information [Line Items]        
Operating (loss) income 21,459 20,851 39,242 39,767
Corporate        
Segment Reporting Information [Line Items]        
Corporate expenses $ (56,741) $ (63,580) $ (121,803) $ (125,283)